Drugs / SR-1 UCB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02765997 | Apr 2017 → Jun 2020 | acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome | Masonic Cancer Center, University of Minnesota | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SR-1 UCB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02765997 ↗ |
| Modality | Cell therapy | “StemRegenin-1 (SR-1) cultured umbilical cord blood transplantation” NCT02765997 ↗ |